His main research concerns Internal medicine, Immunology, Inflammation, Endocrinology and Proinflammatory cytokine. His research is interdisciplinary, bridging the disciplines of Gastroenterology and Internal medicine. Immunology is often connected to Inflammatory bowel disease in his work.
His research in Inflammation intersects with topics in Haematopoiesis, Osteoprotegerin, Bioinformatics, Immunity and Pharmacology. His research in the fields of Adipose tissue and Adiponectin overlaps with other disciplines such as Thrombopoiesis. His Proinflammatory cytokine research incorporates themes from Inflammasome, Interferon gamma, Neopterin, Phytohaemagglutinin and Interleukin.
Herbert Tilg focuses on Internal medicine, Immunology, Endocrinology, Gastroenterology and Inflammation. Internal medicine is represented through his Fatty liver, Disease, Insulin resistance, Cirrhosis and Ulcerative colitis research. His Fatty liver research is multidisciplinary, relying on both Fibrosis, Steatosis and Diabetes mellitus.
His Ulcerative colitis study combines topics in areas such as Crohn's disease and Inflammatory bowel disease. His study involves Cytokine, Immune system, Tumor necrosis factor alpha, Proinflammatory cytokine and Gut flora, a branch of Immunology. Adipose tissue, Adiponectin, Adipokine, Weight loss and Metabolic syndrome are the subjects of his Endocrinology studies.
Herbert Tilg mainly investigates Internal medicine, Disease, Gastroenterology, Fatty liver and Endocrinology. Herbert Tilg interconnects Microbiome, Biopsy, Clinical trial and Gut flora in the investigation of issues within Disease. Herbert Tilg combines subjects such as Diabetes mellitus and Insulin resistance with his study of Fatty liver.
His Endocrinology study focuses on Adipose tissue in particular. Herbert Tilg works mostly in the field of Liver transplantation, limiting it down to topics relating to Liver disease and, in certain cases, Inflammation, as a part of the same area of interest. Herbert Tilg frequently studies issues relating to Immunology and Cirrhosis.
Herbert Tilg spends much of his time researching Internal medicine, Fatty liver, Disease, Immunology and Meta-analysis. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Endocrinology and Pathology. The various areas that Herbert Tilg examines in his Fatty liver study include Diabetes mellitus, Cirrhosis and Phase iii trials.
Herbert Tilg has researched Disease in several fields, including Microbiome, Cardiomyopathy, Pathophysiology and Kidney disease. His Inflammation, Cytokine, Proinflammatory cytokine, Interleukin 17 and Interleukin 23 investigations are all subjects of Immunology research. He usually deals with Insulin resistance and limits it to topics linked to Interferon and Immune system.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adipocytokines: mediators linking adipose tissue, inflammation and immunity.
Herbert Tilg;Alexander R. Moschen.
Nature Reviews Immunology (2006)
EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Giulio Marchesini;Christopher P. Day;Jean Francois Dufour;Ali Canbay.
Journal of Hepatology (2016)
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis†
Herbert Tilg;Alexander R. Moschen.
Hepatology (2010)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollón;Axel Dignass;Vito Annese;Herbert Tilg.
Journal of Crohns & Colitis (2017)
XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease
Arthur Kaser;Ann-Hwee Lee;Andre Franke;Jonathan N. Glickman.
Cell (2008)
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Herbert Tilg;Anna Mae Diehl.
The New England Journal of Medicine (2000)
Visfatin, an adipocytokine with proinflammatory and immunomodulating properties.
Alexander R. Moschen;Arthur Kaser;Barbara Enrich;Birgit Mosheimer.
Journal of Immunology (2007)
Intestinal permeability – a new target for disease prevention and therapy
Stephan C. Bischoff;Giovanni Barbara;Wim Buurman;Theo Ockhuizen.
BMC Gastroenterology (2014)
Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes
Anna M. Wolf;Dominik Wolf;Holger Rumpold;Barbara Enrich.
Biochemical and Biophysical Research Communications (2004)
Inflammatory mechanisms in the regulation of insulin resistance.
Herbert Tilg;Alexander R. Moschen.
Molecular Medicine (2008)
University of Cambridge
Medical University of Vienna
University of Colorado Denver
Innsbruck Medical University
Innsbruck Medical University
Innsbruck Medical University
National Institute for Health Research
Catholic University of the Sacred Heart
University of Verona
University of Innsbruck
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: